Rebopag (Eltrombopag)

Rebopag tablets contain Eltrombopag, a thrombopoietin receptor agonist used to treat low platelet count in conditions such as immune thrombocytopenia (ITP), hepatitis C, and severe aplastic anemia. It works by stimulating bone marrow to produce more platelets, helping reduce bleeding risk. Common side effects include headache, nausea, fatigue, and liver enzyme changes.